1. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma 
Haris Zahoor, MD, James D. Luketich, MD, Ryan M. Levy, MD, Omar Awais, DO, Daniel G. Winger, MS, Michael K. Gibson, MD, PhD, Katie S. Nason, MD, MPH 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 149, Issue 2, Pages (February 2015)
DOI: /j.jtcvs
Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
A, Overall survival after minimally invasive esophagectomy (MIE). Propensity-matched comparison of neoadjuvant therapy followed MIE compared with MIE as primary therapy. The numbers in parenthesis are the number of failure events (deaths) between each time point. B, Propensity-matched comparison of the percentage of patients free of recurrence over time after MIE. Neoadjuvant therapy followed by MIE versus MIE as primary therapy. The numbers in parentheses are the number of failure events (deaths) between each time point. In the primary MIE cohort, 1 patient had an R2 resection and persistent disease and was, therefore, never rendered free of disease. Number at risk, therefore, is 96 at time 0.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

3. Survival of propensity-matched groups.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions